...
首页> 外文期刊>European surgical research >Anti-inflammatory treatment with standardized human serum protein solution reduces local and systemic inflammatory response after hemorrhagic shock.
【24h】

Anti-inflammatory treatment with standardized human serum protein solution reduces local and systemic inflammatory response after hemorrhagic shock.

机译:用标准人血清蛋白溶液进行抗炎治疗可减少失血性休克后的局部和全身炎症反应。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Reperfusion after hemorrhagic shock leads to local and systemic inflammatory response. This study evaluates the effect of a short-term treatment with standardized human serum protein solution (SPS) on the local and systemic inflammatory response in the mesenteric microcirculation in the rat. METHODS: Spontaneously breathing animals underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume-controlled hemorrhagic shock was set by arterial blood withdrawal (2.5 ml/100 g body weight for 60 min), followed by reperfusion for 4 h. SPS (n = 10) or saline 0.9% (controls, n = 10) was given intravenously as a continuous infusion for 30 min at the beginning of reperfusion ('pre-hospital'). This was followed in both groups by substitution of blood and normal saline to support blood pressure ('in-hospital'). Systemic hemodynamics, mesenteric microcirculation and arterial blood gases were monitored before, during and after shock, and for 4 h after initiation of reperfusion. RESULTS: SPS treatment markedly reduced leukocyte/endothelial interaction, and reduced the need for intravenous fluids compared to controls. For the entire observation period, blood pH was unchanged from baseline only in SPS-treated animals. The improvement of base excess and abdominal blood flow persisted for 2 h after SPS infusion. CONCLUSION: Short-term SPS treatment of hemorrhagic shock improved mesenteric microcirculation, arterial blood gases and global hemodynamics, and attenuated the inflammatory response to reperfusion. It may provide clinical benefit when applied at an early phase of reperfusion after hemorrhagic shock.
机译:目的:失血性休克后再灌注会导致局部和全身炎症反应。这项研究评估了标准化人血清蛋白溶液(SPS)短期治疗对大鼠肠系膜微循环中局部和全身炎症反应的影响。方法:自发呼吸的动物接受正中剖腹术和回肠环外化以进行肠系膜微循环的活体显微镜检查。通过抽血(2.5 ml / 100 g体重60分钟)设定体积控制的出血性休克,然后再灌注4 h。在再灌注开始时(“院前”)以连续输注30分钟的方式静脉内注射SPS(n = 10)或生理盐水0.9%(对照组,n = 10)。两组均采用血液和生理盐水替代以支持血压(“医院内”)。在休克前,休克期间和休克后以及再灌注开始后的4小时内,监测全身血流动力学,肠系膜微循环和动脉血气。结果:与对照组相比,SPS治疗显着降低了白细胞/内皮相互作用,并减少了对静脉输液的需要。在整个观察期内,仅在经SPS处理的动物中,血液pH值与基线相比没有变化。 SPS输注后2小时,基础过剩和腹部血流的改善持续。结论:短期SPS治疗失血性休克改善了肠系膜微循环,动脉血气和整体血流动力学,并减弱了对再灌注的炎症反应。当在失血性休克后的再灌注早期应用时,它可能会提供临床益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号